Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

JOURNAL ARTICLE published January 2017 in The Lancet Oncology

Authors: Stephen J Luen | Roberto Salgado | Stephen Fox | Peter Savas | Jennifer Eng-Wong | Emma Clark | Astrid Kiermaier | Sandra M Swain | Jose Baselga | Stefan Michiels | Sherene Loi